A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013

Eurosurveillance

Volumn 18, Issue 21, 2013, Pages 20487-

  Baas, C ^a,b   Barr, I G ^a,b   Fouchier, R A ^c   Kelso, A ^a   Hurt, A C ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF BALLARAT   (Australia)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; AVIAN INFLUENZA VIRUS; COMPARATIVE STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LIMIT OF DETECTION; NONHUMAN; POINT OF CARE TESTING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTIVITY;

EID: 84878238546     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. World Health Organization (WHO). Influenza at the Human-Animal interface. Summary and assessment as of 26 April 2013.Geneva: WHO. [Accessed: 4 May 2013]. Available from: http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_26Apr13.pdf
2. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004;101(5):1356-61.http://dx.doi.org/10.1073/pnas.0308352100 PMid:14745020 PMCid:337057
3. Centers for Disease Control and Prevention (CDC). Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers--Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep. 2012;61(36):726-7. PMid:22971746
4. Belser JA, Bridges CB, Katz JM, Tumpey TM. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis. 2009;15(6):859-65.http://dx.doi.org/10.3201/eid1506.090072 PMid:19523282 PMCid:2727350
5. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med. 2013;368(20):1888-97.http://dx.doi.org/10.1056/NEJMoa1304459 PMid:23577628
6. World Health Organization (WHO). Number of confirmed human cases of avian influenza A(H7N9) reported to WHO. Geneva: WHO. [Accessed: 16 May 2013]. Available from: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/Data_Reports/en/index.html
7. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353(13):1363-73.http://dx.doi.org/10.1056/NEJMra050740 PMid:16192481
8. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, et al. Early administration of oral oseltamivir increases the benifits of influenza treatment. J Antimicrob Chemother. 2003;51(1):123-9.http://dx.doi.org/10.1093/jac/dkg007 PMid:12493796
9. Sakai-Tagawa Y, Ozawa M, Tamura D, Le M, Nidom CA, Sugaya N, et al. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol. 2010;48(8):2872-7.http://dx.doi.org/10.1128/JCM.00439-10 PMid:20554831 PMCid:2916590
10. Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39(2):132-5.http://dx.doi.org/10.1016/j.jcv.2007.03.002 PMid:17452000
11. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013; 25 April: pii: S0140-6736(13)60903-4.http://dx.doi.org/10.1016/S0140-6736(13)60903-4